(Q41055843)

26 September 2017

title

Protein expression and functional analysis of the FHIT gene in human tumor cells (English)

1 reference

26 September 2017

Otterson GA

1

1 reference

26 September 2017

Xiao GH

2

1 reference

26 September 2017

Geradts J

3

1 reference

26 September 2017

Jin F

4

1 reference

26 September 2017

Chen WD

5

1 reference

26 September 2017

Niklinska W

6

1 reference

26 September 2017

Kaye FJ

7

1 reference

26 September 2017

Yeung RS

8

1 reference

26 September 2017

language of work or name

English

0 references

publication date

1 March 1998

1 reference

Journal of the National Cancer Institute

26 September 2017

published in

1 reference

26 September 2017

volume

90

1 reference

26 September 2017

issue

6

1 reference

26 September 2017

page(s)

426-432

1 reference

A nonrandom chromosomal abnormality, del 3p(14–23), in human small cell lung cancer (SCLC)

26 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F90.6.426

Nonrandom structural and numerical chromosome changes in non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F90.6.426

Aphidicolin-induced FRA3B breakpoints cluster in two distinct regions

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F90.6.426

The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F90.6.426

Fhit, a putative tumor suppressor in humans, is a dinucleoside 5',5"'-P1,P3-triphosphate hydrolase

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F90.6.426

Crystal structures of HINT demonstrate that histidine triad proteins are GalT-related nucleotide-binding proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F90.6.426

FHIT gene alterations in head and neck squamous cell carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F90.6.426

Variable FHIT transcripts in non-neoplastic tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F90.6.426

Normal FHIT transcripts in renal cell cancer- and lung cancer-derived cell lines, including a cell line with a homozygous deletion in the FRA3B region

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F90.6.426

DNA sequencing with chain-terminating inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F90.6.426

Identification of a growth suppression domain within the retinoblastoma gene product

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F90.6.426

The FHIT gene 3p14.2 is abnormal in lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F90.6.426

FHIT gene alterations in esophageal cancer and ulcerative colitis (UC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F90.6.426

Replacement of Fhit in cancer cells suppresses tumorigenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F90.6.426

21 January 2018

Identifiers

DOI

10.1093/JNCI/90.6.426

1 reference

26 September 2017

1 reference